Register Login

NEUROCRINE BIOSCIENCES INC (NBIX)

Director SHERWIN STEPHEN A 🟡 adjusted position in 25.0K shares (2 derivative) of NEUROCRINE BIOSCIENCES INC (NBIX) at $167.31 ($7.3M) Transaction Date: Jun 05, 2026 | Filing ID: 000006

Full text
Register to leave comments
  • News bot June 9, 2026, 9:41 p.m.

    🔍 SHERWIN STEPHEN A (Director)

    Company: NEUROCRINE BIOSCIENCES INC (NBIX)

    Report Date: 2026-06-05

    Transaction Summary:

    • Total transactions: 9
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 25,000
    • Total shares sold: 50,000

    Detailed Transactions and Holdings:

    • Acquired 15,000 shares of Common Stock at $53.64 per share (Direct)
      Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 30,860.00 | transaction_form_type: 4
    • Acquired 10,000 shares of Common Stock at $79.79 per share (Direct)
      Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 40,860.00 | transaction_form_type: 4
    • Sold 7,883 shares of Common Stock at $163.807 per share (Direct)
      Date: 2026-06-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 32,977.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 2,549 shares of Common Stock at $164.4394 per share (Direct)
      Date: 2026-06-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 30,428.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 6,896 shares of Common Stock at $165.7926 per share (Direct)
      Date: 2026-06-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 23,532.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 5,829 shares of Common Stock at $166.5567 per share (Direct)
      Date: 2026-06-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,703.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 1,843 shares of Common Stock at $167.3128 per share (Direct)
      Date: 2026-06-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 15,860.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Sold 15,000 shares of Non-Qualified Stock Option at $53.64 per share (Derivative)
      Date: 2026-06-05 | Code: M | Expires: 2027-05-22 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F7
    • Sold 10,000 shares of Non-Qualified Stock Option at $79.79 per share (Derivative)
      Date: 2026-06-05 | Code: M | Expires: 2029-05-22 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F8

    Footnotes:

    • F1: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2026. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
    • F2: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $163.11 to $164.10. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F3: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $164.11 to $164.83. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F4: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $165.11 to $166.09. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F5: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $166.11 to $167.09. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F6: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $167.11 to $167.70. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F7: The option was granted May 22, 2017 and vested in 12 equal monthly installments beginning June 22, 2017.
    • F8: The option was granted May 22, 2019 and vested in 12 equal monthly installments beginning June 22, 2019.

Search

News categories